Paul A. Clark

Extraction of a weak climatic signal by an ecosystem.

Impact of body habitus on quantitative and qualitative image quality in whole-body FDG-PET.

Modulation of bone ingrowth of rabbit femur titanium implants by in vivo axial micromechanical loading.

Sustained release of TGFbeta3 from PLGA microspheres and its effect on early osteogenic differentiation of human mesenchymal stem cells.

Matrices and scaffolds for drug delivery in dental, oral and craniofacial tissue engineering.

Vascularized adipose tissue grafts from human mesenchymal stem cells with bioactive cues and microchannel conduits.

Labeling of mesenchymal stem cells by bioconjugated quantum dots.

Developmental signaling pathways in brain tumor-derived stem-like cells.

Autologous stem cell regeneration in craniosynostosis.

Porous implants as drug delivery vehicles to augment host tissue integration.

Synergistic actions of hematopoietic and mesenchymal stem/progenitor cells in vascularizing bioengineered tissues.

The cancer stem cell paradigm: a new understanding of tumor development and treatment.

Introduction to induced pluripotent stem cells: advancing the potential for personalized medicine.

Significant association of multiple human cytomegalovirus genomic Loci with glioblastoma multiforme samples.

Differential expression of 2',3'-cyclic-nucleotide 3'-phosphodiesterase and neural lineage markers correlate with glioblastoma xenograft infiltration and patient survival.

Activation of multiple ERBB family receptors mediates glioblastoma cancer stem-like cell resistance to EGFR-targeted inhibition.

Inhibition of Na(+)-K(+)-2Cl(-) cotransporter isoform 1 accelerates temozolomide-mediated apoptosis in glioblastoma cancer cells.